Vir

FILE PHOTO: The logo and ticker for Eli Lilly and Co. are displayed on a screen on the floor of the New York Stock Exchange (NYSE) in New York, US, May 18, 2018. REUTERS/Brendan McDermid
Coronavirus chronicle

Lilly-Vir's Covid-19 antibody combo reduced viral load in study

The trial is testing Lilly's bamlanivimab given in combination with Vir and partner GlaxoSmithKline's VIR-7831, the companies said

Photo: Collected
Coronavirus chronicle

GSK, Vir Biotech to expand Covid -19 research partnership for other diseases

Photo: Collected
Coronavirus chronicle

GSK, Vir to test antibody for Covid-19 treatment

FILE PHOTO: The GlaxoSmithKline (GSK) logo on top of GSK Asia House is seen through vertical louvres in Singapore, March 21, 2018. Picture taken March 21, 2018. REUTERS/Loriene Perera
Coronavirus chronicle

GSK, partner Vir join race to find Covid-19 antibody treatment

FILE PHOTO: The GlaxoSmithKline (GSK) logo on top of GSK Asia House is seen through vertical louvres in Singapore, March 21, 2018. Picture taken March 21, 2018. REUTERS/Loriene Perera
Global Economy

GSK to partner with Vir for potential Covid-19 treatments, invest $250 million